Explore 3 Stock Ideas & Industry Insights Download Free Report

Cano Health Inc

Healthcare US CANO

NoneUSD
0.00(0%)

Last update at 2024-05-09T10:34:27.863550Z

Day Range

--
LowHigh

52 Week Range

5.13190.00
LowHigh

Fundamentals

  • Previous Close -
  • Market Cap31.47M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-288.42099M
  • Revenue TTM3102.10M
  • Revenue Per Share TTM1192.10
  • Gross Profit TTM 421.69M
  • Diluted EPS TTM-228.47

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -426.23200M -116.72300M -70.41300M -19.78000M -
Minority interest -221.11700M -98.71700M 0.00000M 0.39M 0.48M
Net income -428.38900M -116.73700M -71.06400M -29.69300M -
Selling general administrative 417.42M 252.13M 103.96M 59.15M -
Selling and marketing expenses - - - - -
Gross profit 421.69M 198.97M 165.23M 76.71M -
Reconciled depreciation 90.64M 49.44M 18.50M 6.82M -
Ebit -89.67000M -102.60500M 42.64M 10.81M 9.27M
Ebitda 0.97M -53.20800M 61.14M 17.63M -
Depreciation and amortization 90.64M 49.40M 18.50M 6.82M -
Non operating income net other 73.06M 69.75M -22.85947M - -
Operating income -89.67000M -102.60500M 42.64M 10.81M -
Other operating expenses 2830.31M 1711.97M 788.81M 350.64M 17.58M
Interest expense 62.49M 51.29M 34.00M 10.16M 0.00000M
Tax provision 2.16M 0.01M 0.65M 0.00000M -
Interest income 0.01M 0.00400M 0.32M 0.32M -
Net interest income -62.48100M -51.28700M -33.68200M -9.84400M -
Extraordinary items - - - - -
Non recurring 350.44M 44.26M - - -
Other items - - - - -
Income tax expense 2.16M 0.01M 0.65M 9.91M -
Total revenue 2738.92M 1609.37M 831.58M 361.38M -
Total operating expenses 513.08M 301.57M 122.46M 65.97M -
Cost of revenue 2317.22M 1410.40M 666.35M 284.67M -
Total other income expense net -336.56200M -14.11800M -113.05300M -30.59100M -
Discontinued operations - - - - -
Net income from continuing ops -428.38900M -116.73700M -28.57276M -19.78000M -
Net income applicable to common shares -207.27200M -18.02000M -28.87969M -19.78000M -8.51000M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 1928.93M 2143.54M 614.19M - -
Intangible assets 793.76M 825.62M 226.35M - -
Earning assets - - - - -
Other current assets 79.60M 19.52M 8.94M - -
Total liab 1434.65M 1344.97M 564.57M - -
Total stockholder equity 255.01M 318.73M 49.62M - -
Deferred long term liab - 0.50M 0.60M - -
Other current liab 70.51M 62.88M 28.83M 71.32M 2.02M
Common stock 0.05M 0.05M 660.20M 123.24M 53.23M
Capital stock 0.05M 0.05M 0.00000M - -
Retained earnings -286.03200M -78.76000M -107.83200M -25.04100M -7.75400M
Other liab 58.70M 142.22M 38.18M 7.44M 22.54M
Good will 480.38M 769.67M 234.33M - -
Other assets 4.82M 13.58M 4.36M 6.35M 5.10M
Cash 27.33M 163.17M 33.81M - -
Cash and equivalents - - - - -
Total current liabilities 208.44M 161.04M 67.18M 86.15M 11.64M
Current deferred revenue - 1.81M 0.99M - -
Net debt 1172.39M 902.11M 431.38M - -
Short term debt 32.20M 23.57M 5.99M - -
Short long term debt 6.44M 7.00M 5.11M - -
Short long term debt total 1199.71M 1065.28M 465.19M - -
Other stockholder equity 540.99M 397.44M -502.74616M -0.13000M -0.12700M
Property plant equipment 309.22M 85.26M 38.13M 19.15M 9.05M
Total current assets 340.75M 317.24M 111.02M 82.88M 32.02M
Long term investments - - - - -
Net tangible assets -227.74400M -450.93600M 574.66M -119.63100M -46.05300M
Short term investments - - 690.31M - -
Net receivables 233.82M 133.43M 67.35M 49.25M 27.16M
Long term debt 997.81M 915.27M 457.62M - -
Inventory - 1.11M 0.92M 0.65M 0.27M
Accounts payable 105.73M 72.77M 31.37M 12.62M 6.69M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity 241.64M 479.84M - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity 0.05M 0.05M 0.00293M - -
Preferred stock total equity - - - - -
Retained earnings total equity -286.03200M -78.76000M -28.88498M - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 4.82M 13.58M 4.36M - -
Deferred long term asset charges - - - - -
Non current assets total 1588.18M 1826.30M 503.17M - -
Capital lease obligations 195.47M 141.69M 2.46M - -
Long term debt total - 915.27M - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -64.15500M -1131.24800M -268.36600M -90.78400M -
Change to liabilities 25.02M 28.07M 2.18M 10.33M 2.25M
Total cashflows from investing activities -64.15500M -1131.24800M -690.00000M -90.78400M -24.30200M
Net borrowings 77.47M 443.46M -0.27406M 73.41M 28.85M
Total cash from financing activities 74.65M 1389.14M 282.22M 132.04M 28.87M
Change to operating activities -49.10000M -32.38200M -1.87200M 1.61M 0.30M
Net income -428.38900M -116.73700M -71.06400M -19.78000M -8.51000M
Change in cash -135.84100M 129.36M 4.62M 25.79M -2.12700M
Begin period cash flow 163.17M 33.81M 29.19M 3.40M -
End period cash flow 27.33M 163.17M 33.81M 29.19M 3.40M
Total cash from operating activities -146.33700M -128.52700M -9.23500M -15.46500M -6.69900M
Issuance of capital stock - - - - -
Depreciation 90.64M 49.44M 18.50M 6.82M 3.79M
Other cashflows from investing activities -14.62600M -1096.89400M -690.00000M 1.88M -2.08600M
Dividends paid 0.00000M 0.00000M -106.14300M -1.16500M 0.94M
Change to inventory - -0.18500M -0.27500M -0.37300M 0.06M
Change to account receivables -106.74300M -15.13500M -30.30900M -17.64000M -14.49500M
Sale purchase of stock - 945.86M 692.46M - -
Other cashflows from financing activities 108.03M 2048.60M 745.70M 154.04M -0.43200M
Change to netincome 301.41M -53.49600M 44.45M 3.03M 9.56M
Capital expenditures 49.53M 34.35M 12.07M 9.31M 5.53M
Change receivables -106.74300M -15.13500M - - -
Cash flows other operating -32.10200M -25.36700M 25.55M - -
Exchange rate changes - - - - -
Cash and cash equivalents changes -135.84100M 129.36M 1.04M - -
Change in working capital -123.23100M -13.28600M -0.55100M -6.07300M -
Stock based compensation 57.66M 27.98M 0.53M 0.18M -
Other non cash items 256.99M -6.12900M 6.78M 3.38M -
Free cash flow -195.86600M -162.88100M -21.30700M -24.77500M -

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CANO
Cano Health Inc
- -% - - - 0.01 1.55 0.39 -1.3289
HCA
HCA Healthcare, Inc.
9.93 2.63% 386.92 13.19 13.66 1.13 293.44 1.77 8.22
FSNUY
Fresenius SE & Co KGaA ADR
0.17 1.50% 11.47 16.87 9.44 0.42 0.78 0.79 5.37
JDHIY
JD Health International Inc
-0.15 3.30% 4.40 62.50 35.97 0.30 2.32 0.16 3.90
JDHIF
JD Health International Inc
- -% 5.85 57.75 32.68 0.29 2.11 0.16 3.90

Reports Covered

Stock Research & News

Profile

Cano Health, Inc. provides primary care medical services to its members in the United States and Puerto Rico. It owns and operates medical centers enabled by CanoPanorama, a proprietary population health management technology-powered platform that provides the healthcare providers at its medical centers with a 360-degree view of their members with actionable insights to improve care decisions and member engagement. The company also operates pharmacies, as well as provides dental services in its medical centers. Cano Health, Inc. was founded in 2009 and is headquartered in Miami, Florida.

Cano Health Inc

9725 NW 117th Avenue, Miami, FL, United States, 33178

Key Executives

Name Title Year Born
Dr. Marlow Hernandez Cano Founder, CEO, Pres & Chairman 1986
Mr. Brian D. Koppy Chief Financial Officer 1969
Mr. Mark Novell Chief Accounting Officer 1964
Mr. David J. Armstrong Esq., J.D. Gen. Counsel, Chief Compliance Officer & Sec. 1966
Dr. Richard B. Aguilar M.D. Chief Clinical Officer 1957
Mr. Bob Camerlinck Chief Operating Officer NA
Eric Santiago Chief Technology Officer NA
Ms. Amy Charley Chief Admin. Officer NA
Ms. Jennifer Fernandez Hevia Chief People Officer NA
Dr. John J. McGoohan IV, D.O. Chief Strategy Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.